Your browser doesn't support javascript.
loading
Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following induction.
Haydu, J Erika; Flamand, Yael; Vedula, Rahul S; Versluis, Jurjen; Charles, Anne; Copson, Kevin M; Stone, Richard M; DeAngelo, Daniel J; Neuberg, Donna; Lindsley, R Coleman; Luskin, Marlise R.
Affiliation
  • Haydu JE; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Flamand Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Vedula RS; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Versluis J; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Charles A; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Copson KM; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Stone RM; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • DeAngelo DJ; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Lindsley RC; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Luskin MR; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Am J Hematol ; 96(7): E259-E262, 2021 07 01.
Article in En | MEDLINE | ID: mdl-33837971

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Anthracyclines / Cytarabine / Induction Chemotherapy / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Am J Hematol Year: 2021 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Anthracyclines / Cytarabine / Induction Chemotherapy / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Am J Hematol Year: 2021 Document type: Article Affiliation country: United States
...